IL6 and cardiac hypertrophy: Double-transgenic mice overexpressing human IL-6 and soluble IL-6R showed no myocardial phenotype at the age of two months but developed cardiac hypertrophy at five months of age [55], suggesting that cardiac remodeling requires chronic exposure to IL-6/IL-6R signaling.